Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1986 1
2014 1
2019 1
2020 4
2021 4
2022 4
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial.
Krauss DJ, Karrison T, Martinez AA, Morton G, Yan D, Bruner DW, Movsas B, Elshaikh M, Citrin D, Hershatter B, Michalski JM, Efstathiou JA, Currey A, Kavadi VS, Cury FL, Lock M, Raben A, Seaward SA, El-Gayed A, Rodgers JP, Sandler HM. Krauss DJ, et al. Among authors: hershatter b. J Clin Oncol. 2023 Jun 10;41(17):3203-3216. doi: 10.1200/JCO.22.02390. Epub 2023 Apr 27. J Clin Oncol. 2023. PMID: 37104748
Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized Trial.
Movsas B, Rodgers JP, Elshaikh MA, Martinez AA, Morton GC, Krauss DJ, Yan D, Citrin DE, Hershatter BW, Michalski JM, Ellis RJ, Kavadi VS, Gore EM, Gustafson GS, Schulz CA, Velker VM, Olson AC, Cury FL, Papagikos MA, Karrison TG, Sandler HM, Bruner DW. Movsas B, et al. Among authors: hershatter bw. J Clin Oncol. 2023 Jun 10;41(17):3217-3224. doi: 10.1200/JCO.22.02389. Epub 2023 Apr 27. J Clin Oncol. 2023. PMID: 37104723 Clinical Trial.
Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus 18F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial.
Lawal IO, Jani AB, Adediran OA, Goyal S, Abiodun-Ojo OA, Dhere VR, Marcus CV, Joshi SS, Master VA, Patel PR, Goodman M, Shelton JW, Kucuk O, Hershatter B, Fielder B, Halkar RK, Schuster DM. Lawal IO, et al. Among authors: hershatter b. J Nucl Med. 2023 Apr;64(4):586-591. doi: 10.2967/jnumed.122.264832. Epub 2022 Nov 3. J Nucl Med. 2023. PMID: 36328489 Free PMC article.
Radiation Facility Volume and Survival for Men With Very High-Risk Prostate Cancer Treated with Radiation and Androgen Deprivation Therapy.
Sebastian N, Goyal S, Liu Y, Janopaul-Naylor JR, Patel PR, Dhere VR, Hanasoge S, Shelton JW, Godette KD, Jani AB, Hershatter B, Fischer-Valuck B, Patel SA. Sebastian N, et al. Among authors: hershatter b. JAMA Netw Open. 2023 Aug 1;6(8):e2327637. doi: 10.1001/jamanetworkopen.2023.27637. JAMA Netw Open. 2023. PMID: 37552479 Free PMC article.
Randomized Trial of Conventional Versus Conventional Plus Fluciclovine (18F) Positron Emission Tomography/Computed Tomography-Guided Postprostatectomy Radiation Therapy for Prostate Cancer: Volumetric and Patient-Reported Analyses of Toxic Effects.
Dhere VR, Schuster DM, Goyal S, Schreibmann E, Hershatter BW, Rossi PJ, Shelton JW, Patel PR, Jani AB. Dhere VR, et al. Among authors: hershatter bw. Int J Radiat Oncol Biol Phys. 2022 Aug 1;113(5):1003-1014. doi: 10.1016/j.ijrobp.2022.04.005. Epub 2022 Apr 11. Int J Radiat Oncol Biol Phys. 2022. PMID: 35417762 Clinical Trial.
Treatment Patterns and Overall Survival Outcomes Among Patients Aged 80 yr or Older with High-risk Prostate Cancer.
Fischer-Valuck BW, Baumann BC, Brown SA, Filson CP, Weiss A, Mueller R, Liu Y, Brenneman RJ, Sanda M, Michalski JM, Gay HA, James Rao Y, Pattaras JG, Jani AB, Hershatter B, Patel SA. Fischer-Valuck BW, et al. Among authors: hershatter b. Eur Urol Open Sci. 2022 Feb 1;37:80-89. doi: 10.1016/j.euros.2021.12.011. eCollection 2022 Mar. Eur Urol Open Sci. 2022. PMID: 35243392 Free PMC article.
Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic Chemotherapy.
Fischer-Valuck BW, Patel SA, Brenneman RJ, Christodouleas J, Sargos P, Kim E, Weiss A, Hershatter B, Rao YJ, Picus J, Roth B, Arora V, Carmona R, Reimers M, Zaghloul MS, Gay H, Michalski JM, Baumann BC. Fischer-Valuck BW, et al. Among authors: hershatter b. Eur Urol Oncol. 2022 Apr;5(2):246-250. doi: 10.1016/j.euo.2022.02.001. Epub 2022 Mar 3. Eur Urol Oncol. 2022. PMID: 35249864 Free PMC article.
Impact of 18 F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy.
Lawal IO, Marcus C, Schuster DM, Goyal S, Adediran OA, Dhere VR, Joshi SS, Abiodun-Ojo OA, Master VA, Patel PR, Fielder B, Goodman M, Shelton JW, Kucuk O, Hershatter B, Halkar RK, Jani AB. Lawal IO, et al. Among authors: hershatter b. Clin Nucl Med. 2023 Apr 1;48(4):e153-e159. doi: 10.1097/RLU.0000000000004590. Epub 2023 Feb 8. Clin Nucl Med. 2023. PMID: 36754362 Free PMC article.
19 results